SV Health Investors targets early-stage biotechnology, early-to-revenue-stage medical devices, and growth-stage healthcare services and digital health companies. The firm leverages deep domain expertise and dual-geography operations to build high-impact precision medicine and tech-enabled healthcare platforms.
About SV Health Investors
SV Health Investors is a long-established healthcare-focused venture firm formerly known as SV Life Sciences, investing across biotech therapeutics, medical devices, and healthcare services and digital health, with offices in Boston and London. The firm operates dedicated strategies that allow it to invest in different parts of the healthcare landscape, and check sizes typically begin at low single-digit millions in initial commitments and extend to fifteen to thirty million dollars or more in cumulative investment over the life of a company through follow-ons. Healthcare AI founders should approach the appropriate strategy depending on the company profile, with digital health and clinical software companies engaging the relevant practice and biotech-focused AI drug discovery teams considering the therapeutics strategy where the AI is anchored to specific assets. Therapeutics teams should expect rigorous scientific diligence, while digital health and devices teams will face commercial and regulatory diligence focused on payer and provider dynamics. Founders should not approach with a generalist software pitch; the lens is healthcare-specific in every strategy. The best entry path is a warm introduction from a portfolio CEO, a healthcare banker, an academic or clinical advisor with SV relationships, or a strategic at a pharma, payer, or provider in the firm’s network. Direct outreach via LinkedIn to a partner aligned with your specific strategy is also a credible path. Expect a partner-track relationship with sector-fluent engagement and a long-horizon orientation.
Founder reviews
Other portfolio companies
Companies in SV Health Investors's portfolio not currently in our directory.
- EpiVax · 2026
- Pivot Point Consulting · 2026
- Draig Therapeutics · 2024
- Leal Therapeutics · 2025
- Artios Pharma
- Alchemab Therapeutics · 2019
- TRexBio
- HPS/PayMedix
Team
Pitch / review this investor
Have you raised from SV Health Investors? Founders only — share your honest experience (anonymous OK, moderated before publishing).